Special Issue "Vaccine on the Effective Management of Insect Vector Born Disease: An Implication for the Management of Vector and Diseases"

Dear Colleagues,

Mosquitoes are crucial vectors that can spread a large number of diseases, more than any other group of arthropods, and can affect a large number of people around the world through the transmission of harmful viruses that cause morbidity and mortality. Specifically, in tropical areas, malaria, yellow fever, dengue and filariasis, as well as many types of encephalitis viruses, are transmitted. Mosquitoes are the superlative disease-causing vector when compared to other species such as ticks and flies. Mosquito vectors play a role as a bridge for pathogens to pass from host animals to humans. Mosquito control, which is the most effective way to reduce mosquito borne-diseases, can be attained through biological control agents and insecticides.

Resistance to some insecticides has been linked to an increase in insecticide metabolism, such as the upregulation of detoxifying enzymes or enzyme structural changes that increase metabolic capacity. There should be a reliable selection of alternatives for mosquito control strategies. Bio-based pesticides, especially from microbes (peptides/strains) and plants (essential oils, crude extracts and secondary metabolites), can have a significant impact when managing arthropod vectors and are less toxic to the nontarget species.

Thus, the present theme of this Special Issue is focused on the search for novel natural products from plants/microbes for the effective management of mosquito-borne diseases.

Dr. Vasantha-Srinivasan Prabhakaran
Prof. Dr. Sengottayan Senthil-Nathan
Dr. Sengodan Karthi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• mosquito vector
• drugs
• herbal extracts
• microbial peptides
• secondary metabolites
• essential oils
• crude extracts
• mycotoxins
• bioactive material
• nontargets
• arthropods
• dengue vector
• malarial vector
• chemical pesticides
• glutathione S-transferase
• cytochrome P-450
• carboxyl esterase
• insect resistance
• chemical characterization
• novel bio-based drugs